Insider Intelligence delivers leading-edge research to clients in a variety of forms, including full-length reports and data visualizations to equip you with actionable takeaways for better business decisions.
In-depth analysis, benchmarks and shorter spotlights on digital trends.
Learn More
Interactive projections with 10k+ metrics on market trends, & consumer behavior.
Learn More
Proprietary data and over 3,000 third-party sources about the most important topics.
Learn More
Industry KPIs
Industry benchmarks for the most important KPIs in digital marketing, advertising, retail and ecommerce.
Learn More
Client-only email newsletters with analysis and takeaways from the daily news.
Learn More
Analyst Access Program
Exclusive time with the thought leaders who craft our research.
Learn More

About Insider Intelligence

Our goal at Insider Intelligence is to unlock digital opportunities for our clients with the world’s most trusted forecasts, analysis, and benchmarks. Spanning five core coverage areas and dozens of industries, our research on digital transformation is exhaustive.
Our Story
Learn more about our mission and how Insider Intelligence came to be.
Learn More
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Contact Us
Speak to a member of our team to learn more about Insider Intelligence.
Contact Us
See our latest press releases, news articles or download our press kit.
Learn More
Advertising & Sponsorship Opportunities
Reach an engaged audience of decision-makers.
Learn More
Browse our upcoming and past events, recent podcasts, and other featured resources.
Learn More
Tune in to eMarketer's daily, weekly, and monthly podcasts.
Learn More


On today's episode, we discuss early initiatives to integrate generative AI into healthcare, the ways in which ChatGPT in healthcare could become a huge liability, and how chatbots can boost patient engagement. "In Other News," we talk about how to turn bad reviews into positive change and how ChristianaCare's subscription primary care offering is a little bit different. Tune in to the discussion with our analysts Rajiv Leventhal and Lisa Phillips.

Consumers see pharmacists as a go-to healthcare source: Pharmacists’ roles and responsibilities evolved during the pandemic. Patients are noticing—and trusting them more than ever.

Quality of care doesn’t beat real revenue: A new AMN Healthcare report on physicians’ bills highlights how healthcare stakeholders’ revenue goals are misaligned.

So far this year, there’s been Google versus Microsoft and TikTok versus … well, everyone. But another battle is emerging as Amazon and Apple go head to head for ad dollars, streaming viewers, and the health vertical.

RPM adoption surges, but faces future roadblocks: We unpack recent trends on remote patient monitoring usage among doctors and factors preventing further growth.

Retail health clinic use soared during the pandemic: We examine what drove growth and forecast the future of retail clinic utilization.

Power to the online patient reviewers: Providers need to react to the online feedback from patients, not just ask for it.

Walgreens’ US healthcare segment is on the path to profit: Retail health investments take center stage as COVID-19 vaccinations plummet.

Patients want to view their test results immediately: We explore the debates still raging about the benefits and risks of giving patients instantaneous access to their test results.

Doctors prove that money doesn’t buy happiness: We look at recent reports on US physicians’ compensation—and what their jobs cost them.

ChristianaCare joins the subscription healthcare market: Incumbents are rolling out bundled virtual primary care services for consumers. Will the trend take off?

Patients are accessing care outside doctors’ offices: Faced with the ongoing shortage of primary care doctors, consumers are getting basic medical services from other sources.

Diabetes drug makers come under gov’t pressure: Big Pharma reacts to Biden administration push for limits on insulin prices. A majority of consumers—and employers—are cheering on cost pressures.

On today's episode, we discuss what omnichannel healthcare should look like, how patients are using social media to find health information, and why physicians don't want to review their patients' wearable data. "In Other News," we talk about what will happen moving forward regarding patient health information being shared for advertising purposes and why Best Buy is teaming up with Atrium Health. Tune in to the discussion with our analysts Rajiv Leventhal and Lisa Phillips.

Consumers see the potential of AI in clinical care: Patients’ comfort levels with AI in healthcare are mixed, but many are bullish on the tech’s ability to improve outcomes and reduce medical errors.

How consumers shop for doctors online: A new Patient Pop survey shows that finding a healthcare provider online is a lot like picking a restaurant or buying shoes. We dig into what they’re looking for before booking a doc.

WeightWatchers enters the Rx business for obesity: Its acquisition of medication-based weight loss program Sequence signals an emerging digital health market trend—but consumers must be cautious of telehealth startups' claims.

Amazon, One Medical, and BetterHelp targeted by the FTC: The federal agency issued a $7.8 million fine over use of patient health data. But it’s also looking for deceptive promises of privacy.

Walmart boosts healthcare to trickle down to its bottom line: It’s adding 28 clinics in 2024 and has new partnerships to address health inequities. The moves could lure more shoppers to higher-margin products, like prescription and OTC medications.

On today's episode, we discuss whether it's time for Google to spin off YouTube, how people feel about targeted ads, what consumers think about using AR to shop, what an in-car TikTok app might look like, the US Supreme Court examining Section 230, paid health leave in the US versus the world, and more. Tune in to the discussion with our analysts Blake Droesch, Evelyn Mitchell, and Paul Verna.